Business Combinations (Tables)

9 Months Ended

Apr. 30, 2013

Summary of Estimated Fair Values of Separately Identifiable Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary purchase price allocation that includes the estimated fair values of the separately identifiable assets acquired and liabilities assumed as of March 2, 2013:

Cash		$	366
Accounts receivable (A)			6,485
Inventory (B)			9,361
Prepaids and other assets			2,861
Property, plant, and equipment			311
Goodwill			48,380
Intangible assets:
Developed technology (estimate useful life of 10 years)	5,900
Customer relationships (weighted-average useful life of 10.6 years)	18,700
Tradename (estimate useful life of 2 years)	900
Total intangible assets			25,500
Other assets			72
Total assets acquired			93,336
Accounts payable and accrued expenses			(5,377	)
Deferred revenue (B)			(813	)
Accrued warranty			(1,169	)
Debt			(784	)
Deferred taxes			(4,895	)
Total liabilities assumed			(13,038	)
Total purchase price		$	80,298

(A) The gross amount due is $8,720, of which $2,235 is expected to be uncollectible. We did not acquire any other class of receivables other than trade receivables as a result of the acquisition of Ultrasonix.

(B) The inventory fair value and deferred revenue adjustments will be amortized over 5 months and 4.5 years, respectively.

Pro Forma Information of Company as of Business Combination

The following unaudited pro forma information for the three and nine months ended April 30, 2013 and 2012 presents consolidated information as if the business combination had occurred on August 1, 2011, which is the first day of our fiscal year 2012:

	Three Months Ended April  30, 2013		Three Months Ended April  30, 2012
Net revenue	$	128,865	$	128,934
Net income		5,045		6,622
Net income per share, basic		0.41		0.54
Net income per share, diluted		0.40		0.53
	Nine Months Ended April 30, 2013		Nine Months Ended April 30, 2012
Net revenue	$	407,575	$	392,987
Net income		20,011		26,918
Net income per share, basic		1.63		2.16
Net income per share, diluted		1.59		2.13